Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis.
Questions
- Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa (RP)? (00:06)
- Could you tell us a little about the 3D neural interface retinal prosthesis you have been investigating? (01:48)
- What have been the early clinical findings with this device? (03:30)
- Which patients are most likely to benefit from this approach and what further studies are planned? (04:13)
- What challenges remain to be resolved in successful restoration of vision in end-stage RP patients? (05:01)
Speaker Disclosure: Results presented are from a clinical trial sponsored by Nano-Retina.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of EURETINA 2020.
